Abstract
Zygomycosis is an invasive and increasingly emerging life-threatening infection. Diabetes is the most common risk factor; however, zygomycosis has increased among patients with haematologic malignancy, which is now the second most common risk factor with an incidence of 16%. Rapid diagnosis and treatment are essential for patient survival. In the Danish literature, only a few cases have been reported. We present two cases of zygomycosis, both with a fatal outcome, and we discuss the pathogenesis and treatment of invasive zygomycosis.
Bidragets oversatte titel | [Zygomycosis (mucormycosis) in patients with haematologic malignancy] |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 173 |
Udgave nummer | 5 |
Sider (fra-til) | 353-4 |
Antal sider | 2 |
ISSN | 0041-5782 |
Status | Udgivet - 2011 |
Emneord
- Absidia
- Adult
- Brain
- Fatal Outcome
- Female
- Humans
- Immunocompromised Host
- Leukemia, Myeloid, Acute
- Lymphoma, T-Cell
- Male
- Middle Aged
- Mucormycosis
- Rhizopus
- Risk Factors
- Tomography, X-Ray Computed